VLA-4 antagonists: Potent inhibitors of lymphocyte migration.
- Published in:
- Medicinal Research Reviews, 2003, v. 23, n. 3, p. 369, doi. 10.1002/med.10044
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2003 AND VI 23 AND IP 3
Results: 6
1
2
Boronic acid compounds as potential pharmaceutical agents.
- Published in:
- Medicinal Research Reviews, 2003, v. 23, n. 3, p. 346, doi. 10.1002/med.10043
- By:
- Publication type:
- Article
3
Selection criteria for drug-like compounds.
- Published in:
- Medicinal Research Reviews, 2003, v. 23, n. 3, p. 302, doi. 10.1002/med.10041
- By:
- Publication type:
- Article
4
In silico prediction of drug-binding strengths to human serum albumin.
- Published in:
- Medicinal Research Reviews, 2003, v. 23, n. 3, p. 275, doi. 10.1002/med.10039
- By:
- Publication type:
- Article
5
Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues (This work was presented at the Symposium on Non-HIV Antivirals at the 224th American Chemical Society Meeting at Boston, MA, August 1822, 2002.)
- Published in:
- Medicinal Research Reviews, 2003, v. 23, n. 3, p. 253, doi. 10.1002/med.10035
- By:
- Publication type:
- Article
6
Recent progress in the development of coumarin derivatives as potent anti-HIV agents (Anti-AIDS Agents 51. For part 50, see Sun I-C, Kashiwada Y, Morris-Natschke SL, Lee KH. Curr Med Chem Submitted.).
- Published in:
- Medicinal Research Reviews, 2003, v. 23, n. 3, p. 322, doi. 10.1002/med.10034
- By:
- Publication type:
- Article